News Conference News TCT 2025 LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI L.A. McKeown October 27, 2025
News Conference News TCT 2024 SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD L.A. McKeown October 29, 2024
News Conference News TCT 2024 Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT Michael O'Riordan October 27, 2024
News Conference News TCT 2021 FAVOR III China Adds Strength to Value of QFR-Guided PCI L.A. McKeown November 04, 2021
News Conference News TCT 2020 IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs L.A. McKeown October 18, 2020
News Conference News TCT 2019 LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD L.A. McKeown September 28, 2019
News Conference News TCT 2019 ‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures L.A. McKeown September 28, 2019
News Conference News TCT 2013 LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD October 30, 2013
Presentation TCT 2013 Per-Lesion Inter-observer Variability and Impact on Syntax Score Presenter: Gerardo Nau, Pablo Lamelas, Mariano Albertal, Jorge Belardi, Lucio Padilla, Sebastian Peralta, Fabricio Torrent, Fernando Cura January 31, 2013
Presentation TCT 2012 5-year THUNDER Follow-Up: Patients with PAD Treated with Uncoated Versus Paccocath Paclitaxel Coated Balloons. Presenter: Gunnar Tepe January 03, 2012